You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Household Contacts of a Person Infected with SARS-CoV-2

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atherosclerosis, Cardiovascular Diseases, Diabetes, Type 2 Trial in North York, Scarborough (Semaglutide Pen Injector)

Recruiting
  • Atherosclerosis
  • +3 more
  • Semaglutide Pen Injector
  • North York, Ontario, Canada
  • +1 more
May 12, 2023

T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • Seoul, Korea, Republic of
    Daewoong pharmatceutical
Oct 23, 2022

Visual Acuity Trial in United States (ACUVUE Oasys 1-Day with HydraLuxe Technology for Astigmatism, ACUVUE Oasys 1-Day with

Completed
  • Visual Acuity
  • ACUVUE Oasys 1-Day with HydraLuxe Technology for Astigmatism
  • ACUVUE Oasys 1-Day with HydraLuxe Technology
  • Rocklin, California
  • +12 more
Mar 21, 2022

Diabetes, Type 2 Trial in Tokyo (NNC0519-0130, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Tokyo, Japan
    Novo Nordisk Investigational Site
May 12, 2023

Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)

Recruiting
  • Refractory Leukemia
  • CALGE-VEN- RIC-MBF
  • Shanghai, Shanghai, China
  • +2 more
May 22, 2023

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )

Not yet recruiting
  • Biliary Carcinoma
  • TQB3454 tablets
  • TQB3454 tablets matching placebo
  • Beijing, Beijing, China
  • +5 more
Aug 4, 2023

A Prospective and Retrospective Interventional Study on

Recruiting
  • Severe Hemophilia A Without Inhibitor
  • serum biomarker.
  • Taipei, Neihu Dist., Taiwan
    Tri-Service General Hospital Hemophilia Care Center
Aug 10, 2023

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation Trial in New York (Renal Denervation, Catheter Ablation)

Not yet recruiting
  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation
  • Renal Denervation
  • Catheter Ablation
  • New York, New York
    Mount Sinai Hospital
Aug 4, 2023

Structural Conditions and Health After Release From Prison

Recruiting
  • Cardiovascular Diseases
  • Health Care Utilization
    • Aurora, Colorado
      Kaiser Permanente Institute for Health Research
    Aug 3, 2023

    Diabetic Peripheral Neuropathy Trial in United States (Engensis, Placebo)

    Recruiting
    • Diabetic Peripheral Neuropathy
    • Engensis
    • Placebo
    • Phoenix, Arizona
    • +15 more
    Nov 3, 2022

    Perioperative Sitagliptin Medication for Reduction of

    Recruiting
    • Systemic Inflammatory Response Syndrome
    • Münster, North Rhine-Westphalia, Germany
      University Hospital Münster
    Feb 10, 2023

    Psoriasis Trial in Kayseri (GN037, Placebo)

    Active, not recruiting
    • Psoriasis
    • Kayseri, Turkey
      Erciyes University IKUM Center
    Jul 26, 2022

    Cardiovascular Diseases, Motivation, Nurse's Role Trial (motivational interviewing based training program, Routine practice)

    Not yet recruiting
    • Cardiovascular Diseases
    • +3 more
    • motivational interviewing based training program
    • Routine practice
    • (no location specified)
    Oct 4, 2023

    HCC Trial in Pisa (Microwave ablation + Occlusafe + DEB-TACE, Microwave ablation + Occlusafe, Microwave ablation + DEB-TACE)

    Recruiting
    • HCC
    • Microwave ablation + Occlusafe + DEB-TACE
    • +2 more
    • Pisa, Italy
      Azienda Ospedaliero-Universitaria Pisana
    Oct 21, 2022

    Radiodermatitis Trial in Valencia (cosmeceutical cream, Placebo)

    Recruiting
    • Radiodermatitis
    • cosmeceutical cream
    • Placebo
    • Valencia, Spain
      Medical Reserarch Institute La Fe
    Jun 7, 2023

    Quality of Life Trial in Baton Rouge (Dietary supplement)

    Recruiting
    • Quality of Life
    • Dietary supplement
    • Baton Rouge, Louisiana
      Pennington Biomedical Research Center
    Sep 13, 2022

    Dental Caries in Children Trial in Cairo (3D printed crowns, Zirconia crowns)

    Recruiting
    • Dental Caries in Children
    • 3D printed crowns
    • Zirconia crowns
    • Cairo, Egypt
      Ain shams university
    Sep 28, 2023

    Solid Tumor, Colorectal Tumors, NSCLC Trial in Korea, Republic of, United States (EU101)

    Recruiting
    • Solid Tumor
    • +2 more
    • Philadelphia, Pennsylvania
    • +4 more
    Jul 12, 2022

    Long-Term Care, Accidental Falls Trial in Bedford (LOCK Falls Program)

    Not yet recruiting
    • Long-Term Care
    • Accidental Falls
    • LOCK Falls Program
    • Bedford, Massachusetts
      VA Bedford HealthCare System, Bedford, MA
    Jun 6, 2023

    3T MRI T2 Mapping Technique in Chondro-labral Pathology of Hip,

    Not yet recruiting
    • Hip Injuries and Disorders
    • Hip Arthrosis
    • T2 mapping 3T MRI + hip arthroscopy
    • Bologna, Italy
      Istituto Ortopedico Rizzoli
    Sep 28, 2023

    Biomechanical Validation of the CATT

    Not yet recruiting
    • Informal Caregivers
    • +2 more
    • Transfer Training with clinician
    • Pittsburgh, Pennsylvania
      VA Pittsburgh Healthcare System University Drive Division, Pitts
    Aug 22, 2023

    Gastrointestinal Tumors Trial (Anti-allergic treatment)

    Not yet recruiting
    • Gastrointestinal Tumors
    • Anti-allergic treatment
    • (no location specified)
    Jun 19, 2023

    Moderate to Severe Nasolabial Folds Trial in Vienna (Saypha Volume Lidocaine)

    Completed
    • Moderate to Severe Nasolabial Folds
    • Saypha Volume Lidocaine
    • Vienna, Austria
    • +2 more
    Jul 19, 2022

    Rheumatoid Arthritis, Autoimmune Diseases, Influenza Trial in Seongnam-si, Seoul (MTX-hold)

    Completed
    • Rheumatoid Arthritis
    • +3 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +2 more
    Dec 14, 2022